Background: The presence of several risk factors (genetic and non-genetic) has greater impact on the risk of premature coronary artery disease (CAD) than single risk factor. Objective: The aim of the study was to establish possible relations between genotypes and alleles of 677C>T polymorphism of MTHFR gene and some traditional risk factors e.g. elevated levels of lipid parameters and smoking in development of premature CAD. Methods: The groups comprised 152 patients with angiographically documented premature CAD (aged 42.9 ± 5.5) and 121 age-matched blood donors (aged 42.3 ± 6.5) were studied. The MTHFR 677C>T polymorphism was genotyped with Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) method. Results: Patients with TT genotype who simultaneously smoked had increased risk of premature CAD compared to non-smoking cases with CC genotype (OR = 24.62). We also found that individuals with TT genotype and elevated LDL-cholesterol (LDL-chol.) level had significantly higher risk of CAD (OR = 9.92) than individuals with normal LDL-chol. level and CC genotype. Conclusions: The present study shows that simultaneous presence of MTHFR TT genotype and smoking or elevated levels of LDL-chol. influences the risk of premature CAD. This findings give interesting contribution to gene-environment interaction problem that may have clinical implications in the future.
introduction
Coronary artery disease has a complex etiology generated by combined effects of both, genetic and environmental factors (1) . The polymorphic genes, encoding products involved in atherosclerotic process, predispose individuals to a greater or lower extent to CAD. However, traditional risk factors, such as cigarette smoking, hypercholesterolemia, hypertension and overweight, interacting with the genetic risk factors (in cumulative or synergistic ways), may increase or not the risk of the disease. it is known that interactions between genetic and environmental factors are very important in subjects with a high-risk genetic profile (2) . Genetic factors have greater contribution to the development of CAD at younger age (3) .
Methylenetetrahydrofolate reductase (MTHFR) catalyzes a reduction of 5,10-methylenetetrahydrofolate to 5-methyletetrahydrofolate that is the carbon donor for the remethylation of homocysteine (Hcys) to methionine (4) . The 677C>T polymorphism in the MTHFR gene influences enzyme thermolability that leads to its decreased activity and to elevated level of plasma Hcys. Since hyperhomocysteinemia causes a chronic inflammatory state it is considered to be a risk factor for CAD, stroke and thrombosis (5-7). Thus, also the 677C>T polymorphism may be considered as a risk factor for CAD (4, 8) .
The objective of the present study was to assess possible relations between genotypes and alleles of 677C>T polymorphism of MTHFR gene and some traditional risk factors e.g. elevated levels of lipid parameters, smoking and overweight in the development of premature CAD.
Materials and methods

Patients and controls
The study population consisted of 273 subjects, white Polish Caucasians, inhabitants of Upper Silesia region (Katowice, Poland).
Group 1 (CAD) comprised 152 unrelated patients with premature CAD confirmed by angiography with more than 50% diameter stenosis of at least one of the major coronary vessels (64 women and 88 men, mean age 42.9 ± 5.5).
Group 2 (Control) comprised 121 age-matched healthy blood donors with no signs of CAD in interview (19 women and 102 men, mean age 42.3 ± 6.5).
ORiGiNAL ARTiCLES
The patients were recruited from the 1st Clinic of Cardiology in the Silesian Center of Cardiology in Katowice during the period 2000-2004. The coronary angiography was performed by means of Judkin's method. Myocardial infarction (Mi) was diagnosed according to recommendations of the Joint European Society of Cardiology/American College of Cardiology Committee (9) . The exclusion criteria from the study was: clinical diagnosis of cardiomyopathy, coagulopathy, collagenoses and acute poisoning (e.g. CO, amphetamine). Individuals with chronic inflammatory or autoimmune disease and any kind of dementia were also excluded. Cardiomyopathies were detected by electrocardiogram, echocardiography and coronarography. Stroke was diagnosed by computed tomography and magnetic resonance imaging. Other diseases, including peripheral artery occlusive disease, were diagnosed on the basis of medical interview, examination and laboratory methods.
Blood donors were recruited from Regional Center of Blood Donor and Blood Treatment in Katowice. The exclusion criterion was CAD or stroke revealed in the course of family history. CAD in this case was defined through its occurrence in at least one of the parents.
The entire patients' group was characterized in respect of concomitant risk factors for atherosclerosis such as hypertension, hyperlipidemia, cigarette smoking, overweight/obesity and diabetes mellitus on the basis of medical interview according to previously described standards (10) .
The study protocol was approved by the Ethics Committee of the Medical University of Silesia in Katowice and all subjects gave written informed consents.
Biochemical analyses
Antecubital venous blood was collected from each participant after an overnight fast, immediately put on ice and transferred to the laboratory for serum separation within 2 hours after being drawn. Only fresh blood serum was used in the study. The levels of lipid parameters like total cholesterol (TC), high-density lipoprotein-cholesterol (HDL-chol.) and triacylglycerols (TG) were measured using enzymatic methods (commercial Analco Kit, warsaw, Poland). The concentration of LDL-chol. was calculated according to the Friedewald formula in subjects with levels of triacylglycerols below 4.4 mmol/l (11).
Analyses of polymorphisms
Genomic DNA was extracted from peripheral lymphocytes using commercial MasterPure genomic DNA purification kit (Epicentre Technologies; Madison, wi, USA). The 677C>T polymorphism of MTHFR was analyzed using PCR-RFLP method. Genotyping of the MTHFR polymorphism was carried out as described previously by Frosst 
Statistical analyses
Data were analyzed using the Statistica 7.1 (STAT-SOFT; Statistica, Tulsa, OK, USA) and the EpiInfo 6 (Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA) softwares. Normality of distribution of quantitative data was computed by Shapiro-wilk W test. The comparison of mean values of quantitative data between all study groups was made using two following tests: the Student's t-test was used when the distribution of some data was normal and Mann-whitney U test, when the distribution of quantitative data differed from normal distribution. Allele frequencies were assessed on the basis of the genotype distribution. Hardy-weinberg equilibrium (HwE) in all groups was tested by a χ 2 test. The comparisons of genotype and allele frequencies between cases and controls was also assessed with the χ 2 test. in case of small number of subjects (< 5) in the analysis, the Fisher's correction was used. Statistical significance was accepted at p < 0.05. To assess an association between alleles or genotypes and the disease odds ratios (OR) as well as their 95% confidence interval (Ci) were computed. The relationships between polymorphic variants and the disease was calculated using uni-and multivariate logistic regression analysis after adjustment for traditional risk factors, such as: smoking, elevated level of TC, LDL-chol., TG, overweight/obesity. The 6 × 2 table approach was used to assess the additive interactions between the genotypes and traditional risk factors. The reference category involves individuals carrying no polymorphic variant and no traditional risk factor.
results
General, biochemical and clinical characteristic of the study groups
General characteristics and levels of biochemical parameters like TC, HDL-, LDL-chol. and TG of the study groups are shown in Table 1 . Cases had significantly higher levels of TC, LDL-cholesterol and TG compared to control group. The mean body mass index (BMi) value was also greater in patients than in controls. There were greater number of smokers among patients compared to controls (58% vs 24%, p < 0.001, OR = 4.48 95% CI 2.56-7.88).
Almost 86% of the cases were recruited to the study in the state of acute coronary syndrome. Among patients there were 81% individuals who suffered from MI and 14.6% of them had more than one Mi. Almost 60% of cases had critical stenosis and multivessel disease. More than 50% of patients had arterial hypertension.
Analyses of polymorphism
The genotype and allele frequencies of 677C>T polymorphism of MTHFR gene in both groups were compatible to HWE (premature CAD p = 0.442, χ 2 = 0.59, control group p = 0.11, χ 2 = 2.56). The term "carriers" were used for subjects with at least one T allele (subjects with genotypes CT+TT). The distributions of the MTHFR genotypes and alleles in the entire groups are shown in Table 2 .
we found that T allele of MTHFR gene was more frequent in cases compared to controls (34% vs 28%). It was also observed that homozygotes TT were twice as common in cases (10%) than in controls (5%) in reference to CC homozygotes (OR = 2.71). This difference was on the borderline of statistical significance (p = 0.083 in multivariate analysis). The T allele carriers were also more common in the patients' group compared to controls (57% vs 51%).
Tab. 1: General characteristics of the study groups
Patients with premature CAD n = 152 
discussion
The 677C>T transition within MTHFR gene results in substitution of the alanine into valine in the mature reductase. This change causes increased thermolability and decreased enzymatic activity and in turn the elevation of the HCys level (4). The MTHFR polymorphism itself is related to CAD only in non-European populations (12) (13) (14) (15) but not in European population (18) . Atherosclerosis and CAD are multifactorial disorders. Clinical phenotype of these diseases may result of interactions between various genetic and environmental factors. Single gene analyses confirmed that associations between single genetic factors and CAD were rather weak. in our opinion, the analysis of possible interactions (synergistic, cumulative or antagonistic) between genetic and non-genetic factors may give more plausible results in the assessment of CAD risk in certain population.
Our study indicates that T allele of MTHFR 677C>T polymorphism as well as TT homozygotes (in comparison to CC "wild"-type homozygotes) were more common in patients with premature CAD than in controls. we observed insignificant trend to higher frequency of T allele carriers in cases compared to controls. we found that presence of the TT genotype and one of the traditional risk factor for CAD, e.g. elevated level of LDL-chol., smoking or overweight, significantly increased the risk of the disease. Higher risk of premature CAD was observed in carriers of T allele who simultaneously smoke compared to non-smoking cases with wild-type genotype. The risk was especially high in smoking subjects bearing TT genotype (OR = 24.62).
The MTHFR 677C>T polymorphism and smoking habit were known to be the main predictors of total HCys levels (15) . Previously, significant interaction between smoking and MTHFR 677C>T polymorphism in the group of patients with lung cancer was found (16) . Surprisingly, the authors demonstrated that CT and TT genotypes of MTHFR polymorphism in association with smoking conferred a decreased risk for lung cancer (16) . in the large study exploring interactions between smoking and 34 SNPs of 24 genes in atherosclerosis, the 677C>T polymorphism of MTHFR gene and smoking significantly interacted in four arteries (17 CAD-coronary artery disease, TC -total cholesterol, LDL-low density lipoprotein, BMi-body mass index, OR-odds ratio, CI-confidence interval * statistically significant data at p < 0.05
TT genotype are more likely to develop atherosclerosis than subjects with CT or CC genotypes. in present study we also found that individuals with TT genotype and elevated LDL-chol. level had significantly higher risk of CAD (OR = 9.92). In Croatian patients with carotid stenosis the carriers of the T allele had higher levels of LDL-chol. compared to CC homozygotes (18) . Yilmaz et al. (19) demonstrated unfavorable effect of MTHFR polymorphism on serum lipid profile that leads to an elevated level of LDL-chol. in renal transplant recipients. The TT subjects in this study group had the highest LDL-chol. levels compared to CC or CT genotypes (19) . Previously a positive correlation between plasma HCys level and cholesterol was observed in patients with hyperhomocysteinemia and in HepG2 cells (20) . Since HCys stimulates the production and secretion of cholesterol and apoB100 in HepG2 cells (20) , the MTHFR polymorphism related to elevated level of HCys may be indirectly associated to the production of cholesterol. Earlier, an interaction between LDL-chol. and HCys was suggested in the atherosclerotic processes (21) .
we demonstrated also a relation between the MTHFR TT genotype and contemporaneous presence of overweight (OR = 10.15). Recently, statistically higher levels of serum HCys were found in the overweight or obese individuals compared to subjects with normal BMi (22) . There are conflicting results showing associations of MTHFR polymorphism and overweight or obesity (23) (24) (25) . Some studies did not show such relations (23, 24) . However, some of them showed higher BMi and waist-to-hip ratio in healthy postmenopausal women being carriers of the 677C>T polymorphism compared to women with the CC genotype (25) . On the other hand, in the study of Frelut et al. (26) the highest value of BMi was found in the obese adolescent girls having CC genotype compared to girls with CT or TT.
Our previous data demonstrated a role of MTHFR polymorphism in the cardio-and cerebrovascular diseases (27, 28) . In the group of patients with CAD we observed that frequency of some double or triple combinations among polymorphisms of the MTHFR, IL-6 and ICAM1 genes, particularly for: MTHFR+ICAM1 and MTHFR+ICAM1+IL-6 patterns, differentiated patients from controls (27) . The odds ratios were especially high in females subgroup (27) . in the group of Polish children after stroke, MTHFR polymorphism seemed to be a risk factor for ischemic stroke, but in opposite to the results in CAD patients, in the male subgroup (28) .
The present study has some limitations: the largest one is low number of analyzed subjects and lack of measurements of HCys and folate levels. Studies based on larger group of patients and controls are needed to confirm obtained results. Another limitation of our study is the fact that part of the included CAD patients were undergoing a treatment with cholesterol-lowering drugs which reflected in serum lipid levels. important issue is also selective control group.
In conclusion, present work showed that the 677C>T polymorphism within MTHFR gene is associated with the premature CAD only in a presence of given environmental risk factors, which is an interesting contribution to gene-environment interaction problem that may have clinical implications in the future. 
